giving semaglutide injection How To Inject In Thigh​ How to Self-Inject GLP-1 Medications

The results were comparable if participants persisted with their medication for one year after their initial prescriptions

Many people know GLP-1 medications for their role in weight management, but research now shows that these therapies may also support blood sugar control, cardiovascular health, inflammation reduction, longevity, cognition, and metabolic health

Medical Disclaimer: Semaglutide (Wegovy, Ozempic) and Tirzepatide (Mounjaro, Zepbound) require a prescription and medical evaluation

Drug manufacturers are exploring an oral option 21 that may lead to greater uptake of these medication within certain segments of the population

Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol

GPLC: Glycine Propionyl-L-Carnitine $45.75 or subscribe to save 10% Out of stock Description GPLC, is a propionyl ester of L-carnitine (PLC) that includes a glycine component